IL23R and cancer: Interleukin 23 receptor (IL-23R) is a key player in the pro-inflammatory signal transduction pathway of the IL-23/IL-17 axis (IL-23→IL-23R→STAT3→Th17→IL-17/IL-17F) and is recognized for its crucial role in inflammatory diseases and cancers [20,21].